Get started
Work

Supplementary Figure S7 from Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure S7. SX-682 treatment does not alter PMN-MDSC suppressive capacity
DOI: 10.1158/1078-0432.22478684.v1
Authors: Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt, Jay Friedman, Lucas A. Horn, Claudia Palena, Jeffrey Schlom, Dean Y. Maeda, John A. Zebala, Paul E. Clavijo, Clint Allen
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361938588
Cites:
Cited by:
Related to: 10